Ελληνικά
English
ΕLPEN
AT A GLANCE
VISION, MISSION, VALUES
50-YEAR+ HISTORY
FINANCIAL STATEMENTS
OUR PEOPLE
PRODUCTS
PRESCRIPTION ONLY MEDICINES
NON-PRESCRIPTION PRODUCTS
ELPENHALER®
CHC PRODUCTS
almora PLUS®
RESEARCH
RESEARCH & DEVELOPMENT
EXPERIMENTAL RESEARCH & TRAINING CENTER
CLINICAL RESEARCH & TRAINING
PUBLICATIONS
REGULATORY AFFAIRS & PHARMACOVIGILANCE
BUSINESS DEVELOPMENT
DOMESTIC MARKETS
INTERNATIONAL BUSINESS DEVELOPMENT
ELPENHALER® INTERNATIONAL OPPORTUNITIES
CONTRACT MANUFACTURING
PRODUCTION
PRODUCTION UNIT
QUALITY & SAFETY POLICY
HOME
PRESS CENTER
PRESS RELEASES
PRESS RELEASES
23 March 2023
Read more
20 October 2022
Read more
21 July 2022
Read more
03 June 2022
Read more
23 May 2022
Read more
15 February 2022
Read more
03 November 2021
Read more
14 October 2021
Read more
08 October 2021
Read more
30 September 2021
Read more
12 July 2021
Read more
28 June 2021
Read more
«
1
2
3
4
5
...
»